Screener
Outlook Therapeutics, Inc. OTLK Q4 2025 earnings
Reported February 17, 2026 · Before market open
Revenue-$1.2MMiss by $4.4M
EPS-$0.22Miss by $0.05
Revenue estimate$3.1M
EPS estimate-$0.17
Next report
Date not yet announcedVersus estimates
Revenue
Diluted EPS
FAQ
- When did Outlook Therapeutics, Inc. report Q4 2025 earnings?
- Outlook Therapeutics, Inc. (OTLK) reported Q4 2025 earnings on February 17, 2026 before market open.
- What were Outlook Therapeutics, Inc.'s Q4 2025 revenue and EPS?
- Outlook Therapeutics, Inc. reported revenue of -$1.2M and eps of $-0.22 for Q4 2025.
- Did Outlook Therapeutics, Inc. beat estimates in Q4 2025?
- Revenue missed the consensus estimate of $3.1M by $4.4M. EPS missed the consensus estimate of $-0.17 by $0.05.
- How did Outlook Therapeutics, Inc.'s Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 75.3% from $-0.89.
- Where can I find Outlook Therapeutics, Inc.'s Q4 2025 SEC filings?
- You can read the 8-K earnings release (0001104659-26-015887) and the 10-Q periodic report (0001104659-26-016554) directly on SEC EDGAR. The filing index links above go to sec.gov.
